Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

<div>Chromatogram of ruxolitinib in Inorpha® at 200 <i>μ</i>g/ml at day 60 and stored at room temperature.</div>

The Scientific World Journal

fig3

Figure 3

Figure 3: Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease 

Figure 3 | Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease 